BME : PANG.MC
$0 (0.0%)
BME
Javier Rivela-Rodriguez
Medical - Diagnostics & Research
Healthcare
PANG.MC
183
ES
EUR
0.27
1.78
1.74
0.27
0.00
$14.52M
3.83
2.48
-18.60
-0.09
-$0.11
-$3.6M
-24.76%
-27.71%
-17.51%
-11.20%
-15.11
0.12
0.12
1/5
0 Analysts
%
3.12
3/9
$5.62M
$32.11M
$10.05M
-$5.12M
No key metrics data available.
| Name | Title |
|---|---|
| Miguel Angel Molina | Executive Director of Research & Development and Member of Scientific Committee |
| Alejandro Garcia Moncayo | Executive Director of Corporate & Chief Financial Officer |
| Alejandro Martinez | Chief Medical Officer & Medical Director at IOR (Hospital Universitari Dexeus) |
| Cristina Masferrer EMBA | Chief Business Officer |
| Rafael Rosell Costa | Chief Scientific Officer, Director, President & Member of Scientific Committee |
| Carmen Albiol | Head of Operations for IOR |
| Javier Rivela-Rodriguez | Co-Founder, Chief Executive Officer & Director |
No votes yet today — be the first to share your view!
About Pangaea Oncology, S.A. (BME:PANG.MC) Stock
Pangaea Oncology, S.A. delivers essential medical services to cancer patients across Spain and other European Union countries. Its extensive offerings encompass advanced molecular diagnostics, which include mutation analysis in tumor tissue and blood, gene amplification and translocation testing, immunohistochemistry, and gene expression profiling. The company is also active in clinical trials and provides in vitro drug profiling, employing techniques like MTT proliferation assays, western blotting, colony formation, migration and invasion assays, and gene silencing. Furthermore, Pangaea operates a specialized Dx platform for validating companion diagnostic platforms, benchmarking them against commercial alternatives, and offering bespoke research and development services to other diagnost ... ic firms. A key focus also involves biomarker discovery, aiming to pinpoint novel targets for targeted therapies in their pre-clinical stages. Established in 2006, Pangaea Oncology, S.A. is headquartered in Barcelona, Spain.
Frequently Asked Questions
What is the current Pangaea Oncology, S.A. (PANG.MC) stock price?
Pangaea Oncology, S.A.(BME:PANG.MC) stock price is $1.55 in the last trading session. During the trading session, PANG.MC stock reached the peak price of $1.75 while $1.48 was the lowest point it dropped to. The percentage change in PANG.MC stock occurred in the recent session was 0.0% while the dollar amount for the price change in PANG.MC stock was $0.
PANG.MC's industry and sector of operation?
The BME listed PANG.MC is part of Medical - Diagnostics & Research industry that operates in the broader Healthcare sector.
Who are the executives of PANG.MC?
Miguel Angel Molina
| Executive Director of Research & Development and Member of Scientific Committee
Alejandro Garcia Moncayo
| Executive Director of Corporate & Chief Financial Officer
Alejandro Martinez
| Chief Medical Officer & Medical Director at IOR (Hospital Universitari Dexeus)
Cristina Masferrer EMBA
| Chief Business Officer
Rafael Rosell Costa
| Chief Scientific Officer, Director, President & Member of Scientific Committee
How many employees does PANG.MC have?
Number of PANG.MC employees currently stands at 183. PANG.MC operates from Sabino Arana, 5-19, Barcelona, CT 08028, ES.
Link for PANG.MC official website?
Official Website of PANG.MC is: https://www.panoncology.com
How do I contact PANG.MC?
PANG.MC could be contacted at phone #34 93 409 79 81 and can also be accessed through its website. PANG.MC operates from Sabino Arana, 5-19, Barcelona, CT 08028, ES.
How many shares of PANG.MC are traded daily?
The average number of PANG.MC shares traded daily for last 3 months was 4K.
What is the market cap of PANG.MC currently?
The market value of PANG.MC currently stands at $55.67M with its latest stock price at $1.55